In this issue:
Phase 2 study of antisense oligonucleotide therapy in acromegaly
Does GH treatment increase comorbidities in patients with NFPA?
ESE clinical guidelines for adrenocortical carcinoma in adults
Prognostic relevance of proliferation-related miRNAs in PNETS
Prognostic significance of MRI texture analysis in patients with NFPA
Risk factors for cardiovascular disease among thyroid cancer survivors
Pro-FHH: a risk equation for diagnosis of parathyroid-related hypercalcemia
Genetic analysis of FTC is prognostic independent of histology
Review: treatment of pituitary tumours with temozolomide
Trastuzumab inhibits pituitary tumour cell growth in vitro
Please login below to download this issue (PDF)